Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheila A Doggrell

Showing results (61-70 of 220) with videos related to

Pageof 22
Sort By:
Expert Opinion on Pharmacotherapy|August 10, 2005
CLARITY about the use of clopidogrel in patients with acute coronary syndromes and myocardial infarctionSheila A Doggrell
Expert Opinion on Pharmacotherapy|December 23, 2022
A new role for an old drug: acetazolamide in decompensated heart failureSheila A Doggrell
Drugs of Today (Barcelona, Spain : 1998)|May 28, 2003
Is Ramipril the pril for diabetes and kidney disease?Sheila A. Doggrell
Expert Opinion on Investigational Drugs|December 19, 2003
The potential of activation of somatostatinergic neurotransmission with FK960 in Alzheimer's diseaseSheila A Doggrell
Expert Opinion on Pharmacotherapy|March 17, 2010
Good results for early treatment of clinically isolated syndrome prior to multiple sclerosis with interferon beta-1b and glatiramer groupSheila A Doggrell
Expert Opinion on Pharmacotherapy|May 1, 2019
Clinical trials of eicosapentaenoic acid (EPA) prescription products for the treatment of hypertriglyceridemiaSheila A Doggrell
Expert Opinion on Therapeutic Targets|April 28, 2011
Bitter taste receptors as a target for bronchodilationSheila A Doggrell
Expert Opinion on Investigational Drugs|February 15, 2011
A new approach to Parkinson's disease: inhibition of leucine-rich repeat kinase-2Sheila A Doggrell
Expert Opinion on Therapeutic Targets|July 1, 2011
CX3CR1 as a target for airways inflammationSheila A Doggrell
Drug News & Perspectives|January 20, 2006
Highlights from the First International Conference in Vascular Medicine, held August 26-28, 2005, in Melbourne, Australia. Vascular medicine in Australia and GermanySheila A Doggrell
Pageof 22

Showing results (61-70 of 220) with videos related to

Sort By:
Pageof 22
Expert Opinion on Pharmacotherapy|August 10, 2005
CLARITY about the use of clopidogrel in patients with acute coronary syndromes and myocardial infarctionSheila A Doggrell
Expert Opinion on Pharmacotherapy|December 23, 2022
A new role for an old drug: acetazolamide in decompensated heart failureSheila A Doggrell
Drugs of Today (Barcelona, Spain : 1998)|May 28, 2003
Is Ramipril the pril for diabetes and kidney disease?Sheila A. Doggrell
Expert Opinion on Investigational Drugs|December 19, 2003
The potential of activation of somatostatinergic neurotransmission with FK960 in Alzheimer's diseaseSheila A Doggrell
Expert Opinion on Pharmacotherapy|March 17, 2010
Good results for early treatment of clinically isolated syndrome prior to multiple sclerosis with interferon beta-1b and glatiramer groupSheila A Doggrell
Expert Opinion on Pharmacotherapy|May 1, 2019
Clinical trials of eicosapentaenoic acid (EPA) prescription products for the treatment of hypertriglyceridemiaSheila A Doggrell
Expert Opinion on Therapeutic Targets|April 28, 2011
Bitter taste receptors as a target for bronchodilationSheila A Doggrell
Expert Opinion on Investigational Drugs|February 15, 2011
A new approach to Parkinson's disease: inhibition of leucine-rich repeat kinase-2Sheila A Doggrell
Expert Opinion on Therapeutic Targets|July 1, 2011
CX3CR1 as a target for airways inflammationSheila A Doggrell
Drug News & Perspectives|January 20, 2006
Highlights from the First International Conference in Vascular Medicine, held August 26-28, 2005, in Melbourne, Australia. Vascular medicine in Australia and GermanySheila A Doggrell
Pageof 22